Home/Healthcare/Diagnostics/Point of Care Diagnostic Market

Point of Care Diagnostic Market - Strategic Insights and Forecasts (2026-2031)

Market Trends, Opportunities & Forecast By Testing (Cardio-Metabolic Monitoring Kits, Infectious Disease Testing Kits, Glucose Monitoring Kits, Coagulation Monitoring Kits, Tumor/Cancer Marker, Pregnancy & Fertility Testing, Urinalysis Testing Kit, Hematology Testing, Others), By Platform (Lateral Flow Assay, Dipsticks, Microfluids, Molecular Diagnostics, Others), By Mode (Prescription, Over-The-Counter (OTC)), By End-User (Hospitals, Diagnostics Centers, Others), and Geography

Market Size in 2026
USD 38.94 billion
Market Size in 2031
USD 52.11 billion
CAGR
6.0%
Study Period
2021-2031
$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061612934
PublishedMay 2026
Pages151
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The Point of Care Diagnostic market is forecast to reach USD 52.11 billion by 2031, growing from USD 38.94 billion in 2026. This represents a compound annual growth rate (CAGR) of 6.0% over the forecast period, reflecting significant expansion in the sector.

Key market drivers include the increased availability of portable, hand-held, and transportable diagnostic devices, which enable testing outside traditional hospital settings. Additionally, the growing global prevalence of chronic diseases like diabetes (537 million adults globally in 2021) and cardiovascular diseases, alongside infectious diseases such as HIV and tuberculosis, significantly fuels demand.

North America is anticipated to demonstrate significant growth in the Point of Care Diagnostic market during the forecast period. This regional expansion is driven by factors such as an increase in the number of COVID-19 cases and advanced medical infrastructure.

Point of Care Diagnostic tests are increasingly being adopted outside conventional hospitals, with a significant shift towards home care, emergency care facilities, and inconvenience clinics. This expansion makes testing more accessible and efficient for evaluation, diagnosis, prognosis, and screening, improving overall patient care.

The high prevalence of chronic and infectious diseases directly boosts the demand for Point of Care Diagnostics by requiring efficient and accessible testing. For instance, the management of 20.6 million people living with HIV globally in 2019 and India's 2.64 million tuberculosis cases in 2020 highlights the critical role POC tests play in improving disease management and accelerating treatment.

The future outlook and competitive landscape of the Point of Care Diagnostic market are significantly shaped by the advent of portable, hand-held, and transportable diagnostic devices. These innovations enable testing close to the patient, facilitating quick access to a wide range of health factors and lowering the risk of potential errors, thereby driving market demand and competitive offerings.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon